Vanguard Capital Management
INDV icon

Vanguard Capital Management’s Indivior Pharmaceuticals INDV Stock Holding History

Vanguard Capital Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$225M Sell
5,495,486
-91,090
-2% -$3.3M ﹤0.01% 1058
2026
Q1 		$170M Buy
+5,586,576
New +$185M ﹤0.01% 1155

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Vanguard Capital Management's INDV Position: Q2 2026 in Review

Vanguard Capital Management reduced its Indivior Pharmaceuticals (INDV) stake by 1.6% in Q2 2026, selling an estimated $3.3M and leaving 5,495,486 shares worth $225M. The position accounts for ﹤0.01% of the portfolio, ranked #1058.

Vanguard Capital Management first reported a position in INDV in Q1 2026 and has held it in 2 quarters since. 315 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Vanguard Capital Management held 5,495,486 shares of Indivior Pharmaceuticals worth $225M as of Q2 2026.
  • Vanguard Capital Management sold 91,090 Indivior Pharmaceuticals shares in Q2 2026, an estimated $3.3M.
  • Indivior Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #1058 holding.
  • Vanguard Capital Management first reported a position in Indivior Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 315 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.